The Enterprise Value as of December 2024 (TTM) for Nxera Pharma Co., Ltd. (SOLTF) is 108.77B

According to Nxera Pharma Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 108.77B. This represents a change of -29.01% compared to the average of 153.21B of the last 4 quarters.

Nxera Pharma Co., Ltd. (SOLTF) Historical Enterprise Value (quarterly & annually)

How has SOLTF Enterprise Value performed in the past?

The mean historical Enterprise Value of Nxera Pharma Co., Ltd. over the last ten years is 134.08B. The current 108.77B Enterprise Value has changed 8.01% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Enterprise Value was at its highest in in the June 2016 quarter at 306.48B. The Enterprise Value was at its lowest in in the December 2018 quarter at 0.

Nxera Pharma Co., Ltd. (SOLTF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nxera Pharma Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nxera Pharma Co., Ltd. (SOLTF) Average Enterprise Value

How has SOLTF Enterprise Value performed in the past?

The current Enterprise Value of Nxera Pharma Co., Ltd. (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nxera Pharma Co., Ltd. (SOLTF) Enterprise Value vs. Peers

How is SOLTF’s Enterprise Value compared to its peers?

Nxera Pharma Co., Ltd.’s Enterprise Value is greater than Gain Therapeutics, Inc. (31.84M), greater than BioVie Inc. (21.36M), greater than IN8bio, Inc. (18.93M), greater than NewAmsterdam Pharma Company N.V. (2.34B), greater than Cue Biopharma, Inc. (43.61M), greater than uniQure N.V. (660.69M), greater than Rocket Pharmaceuticals, Inc. (1.18B), greater than Rhythm Pharmaceuticals, Inc. (3.36B), greater than Solid Biosciences Inc. (127.34M), greater than MeiraGTx Holdings plc (441.38M), greater than Apellis Pharmaceuticals, Inc. (4.11B), greater than Blueprint Medicines Corporation (6.11B), greater than Karuna Therapeutics, Inc. (12.43B), greater than Mirati Therapeutics, Inc. (3.91B), greater than Day One Biopharmaceuticals, Inc. (852.53M), greater than VectivBio Holding AG (848.58M), greater than AVROBIO, Inc. (-85302404.00), greater than Zura Bio Limited (-30863593.00), greater than Elevation Oncology, Inc. (18.40M), greater than Hepion Pharmaceuticals, Inc. (4.14M),

Build a custom stock screener for Nxera Pharma Co., Ltd. (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nxera Pharma Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nxera Pharma Co., Ltd. (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nxera Pharma Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.